crazy leaf tirzepatide gip/glp-1 GLP-1 & GIP Weight Loss Medication A monthly GLP-1 dose could

Its dual mechanism as a GLP-1 receptor agonist provides powerful effects on both glycemic control and body weight regulation, with efficacy that exceeds previous pharmacological approaches

In India, the patent for semaglutide expires in March 2026, and at least 15 drugmakers are in the fray to tap the opportunity

When the mucosal barrier is healthy and intact, the immune system functions better, the gut is less inflamed, and digestion and nutrient absorption both improve.*

Glucagon-like peptide-1 receptor agonists, originally developed for the treatment of metabolic disorders, have recently emerged as promising candidates for the management of substance use disorders

Understanding the mechanism behind this side effect and practical management techniques can help you stay comfortable while your body adjusts to the medication